Fundraising FoxBreakout Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
A-Alpha Bioaalphabio.comin𝕏Series A · Jul 2023 · $22M
A-Alpha Bio uses synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions for pharmaceutical discovery and development.
AI & Machine LearningBiotechDeep TechSeattle, US
David Younger, PhD(Chief Executive Officer & Co-Founder)Randolph Lopez, PhD(Chief Technology Officer & Co-Founder)David Younger(Founder)inRandolph Lopez(Founder)in
Co-investorsAngel Collective Opportunity FundFarvatn VentureLux CapitalMadrona Venture GroupPlanet 9 CapitalBoom Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.